Buy Aarti Drugs, target price Rs 536: Axis Securities
Aarti Drugs Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2023.

Aarti Drugs Ltd., incorporated in the year 1984, is a Small Cap company (having a market cap of Rs 4490.57 Crore) operating in Pharmaceuticals sector.
Aarti Drugs Ltd. key Products/Revenue Segments include Pharmaceuticals for the year ending 31-Mar-2023.
Financials
For the quarter ended 31-03-2024, the company reported a Consolidated Total Income of Rs 621.07 Crore, up 2.22 % from last quarter Total Income of Rs 607.61 Crore and down -16.44 % from last year same quarter Total Income of Rs 743.28 Crore. Company reported net profit after tax of Rs 47.31 Crore in latest quarter.
Promoters held 57.13 per cent stake in the company as of 31-Mar-2024, while FIIs owned 2.56 per cent, DIIs 5.99 per cent.
Download ET Markets APP